Is a complete INCR research report available?

No complete published report is available for InterCure Ltd. (INCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

InterCure Ltd. (INCR)

NASDAQ: INCR · USD

$4.50

+0.03 (+0.7%)· Recorded snapshot

Market cap	53.1M
Revenue (ttm)	84.8M
Net income (ttm)	-11.2M
EPS (ttm)	-$1.06
Shares out	10.9M
Volume	580
Beta	0.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 84.8M
Net income (ttm): -11.2M
EPS (ttm): -$1.06
Market cap: 53.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001857030
Company name	InterCure Ltd.
Country	Israel
Country code	US
Earnings date	2026-11-10
Earnings time	bmo
Employees	285
Employees change	-35
Employees growth	-10.94%
Enterprise value	$97.3M
Exchange	NASDAQ
Financial currency	ILS
Financial report date	2025-12-31
First seen	2026-05-09
Fiscal year end	December
Founded	1994
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
Is SPAC	No
ISIN number	IL0011063760
Last 10-K release date	2026-04-30
Last earnings date	2026-04-30
Last refreshed	2026-10-28
Last stock split date	2026-08-24
Last stock split type	Reverse
Market cap	$53.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$4.50
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	INCR
Website	https://www.intercure.co

Metric

Value

Amount currency

USD

CIK code

0001857030

Company name

InterCure Ltd.

Country

Israel

Country code

Earnings date

2026-11-10

Earnings time

bmo

Employees

285

Employees change

-35

Employees growth

-10.94%

Enterprise value

$97.3M

Exchange

NASDAQ

Financial currency

ILS

Financial report date

2025-12-31

First seen

2026-05-09

Fiscal year end

December

Founded

1994

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Is SPAC

ISIN number

IL0011063760

Last 10-K release date

2026-04-30

Last earnings date

2026-04-30

Last refreshed

2026-10-28

Last stock split date

2026-08-24

Last stock split type

Reverse

Market cap

$53.1M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$4.50

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

INCR

Website

https://www.intercure.co

Metric	Value
Earnings yield	-23.65%
EV/FCF	22.76x
EV/Sales	1.14x
FCF / EV yield	4.39%
FCF yield	8.07%
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(FCF - SBC) ratio	15.16x
P/(OCF - SBC) ratio	11.43x
P/B ratio	0.42x
P/FCF ratio	12.39x
P/OCF ratio	9.78x
P/S ratio	0.62x
Price / tangible book value	0.95x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-23.65%

EV/FCF

22.76x

EV/Sales

1.14x

FCF / EV yield

4.39%

FCF yield

8.07%

Industry forward P/E

13.86x

Industry P/E

173.47x

P/(FCF - SBC) ratio

15.16x

P/(OCF - SBC) ratio

11.43x

P/B ratio

0.42x

P/FCF ratio

12.39x

P/OCF ratio

9.78x

P/S ratio

0.62x

Price / tangible book value

0.95x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-24.89%
EBITDA margin	-20.48%
FCF margin	4.92%
Gross margin	15.06%
Operating margin	-24.89%
Pretax margin	-16.32%
Profit margin	-13.22%
Profit per employee	$-39,303
Revenue per employee	$297,387
ROA	-5.78%
ROA (5Y)	-1.23%
ROCE	-14.12%
ROE	-9.27%
ROE (5Y)	-5.71%
ROIC	-12.62%
ROIC (5Y)	-3.31%
SBC / revenue	0.9%
Tax / revenue	-2.71%

Metric

Value

EBIT margin

-24.89%

EBITDA margin

-20.48%

FCF margin

4.92%

Gross margin

15.06%

Operating margin

-24.89%

Pretax margin

-16.32%

Profit margin

-13.22%

Profit per employee

$-39,303

Revenue per employee

$297,387

ROA

-5.78%

ROA (5Y)

-1.23%

ROCE

-14.12%

ROE

-9.27%

ROE (5Y)

-5.71%

ROIC

-12.62%

ROIC (5Y)

-3.31%

SBC / revenue

0.9%

Tax / revenue

-2.71%

Metric	Value
EPS growth years	1
FCF growth (QoQ)	-51.54%
FCF growth 3Y	-25.01%
Gross profit growth	-3.21%
Gross profit growth (Q)	-98.68%
Gross profit growth 3Y	-38.15%
Gross profit growth 5Y	3.92%
Net income growth years	1
OCF growth (QoQ)	-61.94%
OCF growth 3Y	-31%
OCF growth 5Y	16.36%
Revenue growth	13.13%
Revenue growth (Q)	23.94%
Revenue growth (QoQ)	7.83%
Revenue growth 10Y	69.27%
Revenue growth 3Y	-11.41%
Revenue growth 5Y	32.96%
Revenue growth years	1

Metric

Value

EPS growth years

FCF growth (QoQ)

-51.54%

FCF growth 3Y

-25.01%

Gross profit growth

-3.21%

Gross profit growth (Q)

-98.68%

Gross profit growth 3Y

-38.15%

Gross profit growth 5Y

3.92%

Net income growth years

OCF growth (QoQ)

-61.94%

OCF growth 3Y

-31%

OCF growth 5Y

16.36%

Revenue growth

13.13%

Revenue growth (Q)

23.94%

Revenue growth (QoQ)

7.83%

Revenue growth 10Y

69.27%

Revenue growth 3Y

-11.41%

Revenue growth 5Y

32.96%

Revenue growth years

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$3.8M
EBIT	$-21.1M
EBITDA	$-17.4M
EPS	$-1.06
FCF per share	$0.39
Financing cash flow	$-14.6M
Free cash flow	$4.3M
Free cash flow minus SBC	$3.5M
Gross profit	$12.8M
Income taxes	$-2.3M
Investing cash flow	$-624,529
Net borrowing	$-9.3M
Net cash flow	$-10M
Net income	$-11.2M
Operating cash flow minus SBC	$4.6M
Operating income	$-21.1M
Revenue	$84.8M
Stock-based compensation	$761,920

Metric

Value

Capital expenditures

$-1.1M

Depreciation and amortization

$3.8M

EBIT

$-21.1M

EBITDA

$-17.4M

EPS

$-1.06

FCF per share

$0.39

Financing cash flow

$-14.6M

Free cash flow

$4.3M

Free cash flow minus SBC

$3.5M

Gross profit

$12.8M

Income taxes

$-2.3M

Investing cash flow

$-624,529

Net borrowing

$-9.3M

Net cash flow

$-10M

Net income

$-11.2M

Operating cash flow minus SBC

$4.6M

Operating income

$-21.1M

Revenue

$84.8M

Stock-based compensation

$761,920

Metric	Value
Altman Z-Score	0.15
Book value per share	$11.37
Debt / equity	0.46
Debt / FCF	13.48
Goodwill	$70.2M
Interest coverage	-3.42
Long-term assets	$115.1M
Long-term liabilities	$23.6M
Net cash (debt)	$-42.8M
Net cash / market cap	-81.03%
Net debt / equity	0.34
Net debt / FCF	10.04
Piotroski F-Score	4
Property, plant and equipment	$32.9M
Shareholders' equity	$124.3M
Tangible book value	$55.6M
Tangible book value per share	$5.09
Total assets	$216.6M
Total cash	$14.6M
Total debt	$57.4M
Total liabilities	$92.3M
WACC	8.13%

Metric

Value

Altman Z-Score

0.15

Book value per share

$11.37

Debt / equity

0.46

Debt / FCF

13.48

Goodwill

$70.2M

Interest coverage

-3.42

Long-term assets

$115.1M

Long-term liabilities

$23.6M

Net cash (debt)

$-42.8M

Net cash / market cap

-81.03%

Net debt / equity

0.34

Net debt / FCF

10.04

Piotroski F-Score

Property, plant and equipment

$32.9M

Shareholders' equity

$124.3M

Tangible book value

$55.6M

Tangible book value per share

$5.09

Total assets

$216.6M

Total cash

$14.6M

Total debt

$57.4M

Total liabilities

$92.3M

WACC

8.13%

Metric	Value
Asset turnover	0.37
Current assets	$101.5M
Current liabilities	$68.7M
Current ratio	1.48
Inventory turnover	2.01
Net working capital	$50.1M
Quick ratio	0.91
Working capital	$32.1M
Working capital turnover	0.57

Metric

Value

Asset turnover

0.37

Current assets

$101.5M

Current liabilities

$68.7M

Current ratio

1.48

Inventory turnover

2.01

Net working capital

$50.1M

Quick ratio

0.91

Working capital

$32.1M

Working capital turnover

0.57

Metric	Value
Buyback yield / dilution	-17.17%
Dividend yield	0%
Shareholder yield	-17.17%

Metric

Value

Buyback yield / dilution

-17.17%

Dividend yield

Shareholder yield

-17.17%

Metric	Value
150-day SMA	$4.73
1D price change	0.67%
1M price change	-13.63%
1M total return	-13.63%
1W price change	1.81%
1W total return	1.81%
1Y price change	-38.78%
1Y return CAGR	-38.8%
1Y total return	-38.78%
20-day SMA	$4.82
200-day SMA	$4.63
3M price change	-0.33%
3M total return	-0.33%
3Y price change	-12.62%
3Y return CAGR	-4.4%
3Y total return	-12.62%
50-day SMA	$5.11
50-day SMA vs 200-day SMA	50over200
52-week high	$7.55
52-week high date	2025-12-17
52-week low	$3.40
52-week low date	2025-12-31
5Y price change	-86.61%
5Y return CAGR	-33.11%
5Y total return	-86.61%
6M price change	0.11%
6M total return	0.12%
All-time high	$49.95
All-time high date	2021-04-13
All-time low	$1.50
All-time low date	2020-03-16
Average true range (ATR)	$0.24
Average volume	3.8K
Beta (5Y)	0.64
Change from 52-week high	-40.39%
Change from 52-week low	32.35%
Change from all-time high	-90.99%
Change from all-time low	200%
Change from open	2.11%
Day's gap	-1.41%
Dollar volume	$2,610
High price	$4.53
Low price	$4.25
Monthly RSI	39.81
Open price	$4.41
Position in 52-week range	89.61%
Previous close	$4.47
Price vs 150-day SMA	-4.78%
Price vs 20-day SMA	-6.54%
Price vs 200-day SMA	-2.7%
Price vs 50-day SMA	-11.85%
Relative volume	0.15
RSI	39.85
Sharpe ratio	-0.47
Sharpe ratio (3Y)	0.16
Sharpe ratio (5Y)	-0.35
Sortino ratio	-0.66
Sortino ratio (3Y)	0.37
Sortino ratio (5Y)	-0.46
Volume	580
Weekly RSI	44.61
YTD price change	-1.1%
YTD total return	-1.1%

Metric

Value

150-day SMA

$4.73

1D price change

0.67%

1M price change

-13.63%

1M total return

-13.63%

1W price change

1.81%

1W total return

1.81%

1Y price change

-38.78%

1Y return CAGR

-38.8%

1Y total return

-38.78%

20-day SMA

$4.82

200-day SMA

$4.63

3M price change

-0.33%

3M total return

-0.33%

3Y price change

-12.62%

3Y return CAGR

-4.4%

3Y total return

-12.62%

50-day SMA

$5.11

50-day SMA vs 200-day SMA

50over200

52-week high

$7.55

52-week high date

2025-12-17

52-week low

$3.40

52-week low date

2025-12-31

5Y price change

-86.61%

5Y return CAGR

-33.11%

5Y total return

-86.61%

6M price change

0.11%

6M total return

0.12%

All-time high

$49.95

All-time high date

2021-04-13

All-time low

$1.50

All-time low date

2020-03-16

Average true range (ATR)

$0.24

Average volume

3.8K

Beta (5Y)

0.64

Change from 52-week high

-40.39%

Change from 52-week low

32.35%

Change from all-time high

-90.99%

Change from all-time low

200%

Change from open

2.11%

Day's gap

-1.41%

Dollar volume

$2,610

High price

$4.53

Low price

$4.25

Monthly RSI

39.81

Open price

$4.41

Position in 52-week range

89.61%

Previous close

$4.47

Price vs 150-day SMA

-4.78%

Price vs 20-day SMA

-6.54%

Price vs 200-day SMA

-2.7%

Price vs 50-day SMA

-11.85%

Relative volume

0.15

RSI

39.85

Sharpe ratio

-0.47

Sharpe ratio (3Y)

0.16

Sharpe ratio (5Y)

-0.35

Sortino ratio

-0.66

Sortino ratio (3Y)

0.37

Sortino ratio (5Y)

-0.46

Volume

580

Weekly RSI

44.61

YTD price change

-1.1%

YTD total return

-1.1%

Metric	Value
Float	7.2M
Float percentage	65.89%
Shares change (QoQ)	-10.76%
Shares change (YoY)	17.17%
Shares held by insiders	39.17%
Shares held by institutions	2.88%
Shares outstanding	10.9M
Short % of float	0.06%
Short % of shares	0.04%
Short ratio	0.6 days

Metric

Value

Float

7.2M

Float percentage

65.89%

Shares change (QoQ)

-10.76%

Shares change (YoY)

17.17%

Shares held by insiders

39.17%

Shares held by institutions

2.88%

Shares outstanding

10.9M

Short % of float

0.06%

Short % of shares

0.04%

Short ratio

0.6 days

InterCure Ltd. (INCR)

Price

Financial snapshot

Fair-value bridge

Latest news · INCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INCR

Frequently asked questions